1 year return (CAGR)
-0.51%
Larimar Therapeutics Inc Exchange (NASDAQ, USD)
LRMR
3.91
+0.13 (+3.44%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
0.69%
5 year return (CAGR)
-23.48%
10 year return (CAGR)
-19.77%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
406.18M
Price/Sales
-
Ent value
351.42M
Price/Book
3.19
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.67%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.78 |
| Daily high | 3.94 |
| Daily low | 3.70 |
| Daily Volume | 857K |
| All-time high | 616.08 |
| 1y analyst estimate | 14.30 |
| Beta | 0.75 |
| EPS (TTM) | -1.66 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LRMR | S&P500 | |
| Current price drop from All-time high | -99.37% | -2.63% |
| Highest price drop | -99.75% | -56.47% |
| Date of highest drop | 5 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -86.89% | -10.68% |
| Avg time to new high | 103 days | 12 days |
| Max time to new high | 2890 days | 1805 days |
News
